The U.S. circulating tumor cells market size was estimated at USD 4.45 billion in 2023 and is expected to grow at a CAGR of 12.77% from 2024 to 2030. Some key drivers are increased awareness of cancer treatment and improved healthcare facilities. Technological developments, in ... Read More »
April 2024The U.S. genotyping market size was estimated at USD 6.42 billion in 2023 and is expected to grow at a CAGR of 13.7% from 2024 to 2030. Rising prevalence of genetic disorders & cancer, technological advancements, increased focus on developing personalized medicine, and increasing R&a... Read More »
April 2024The U.S. Cell therapy market size was valued at USD 2.66 billion in 2023 and is anticipated to grow at a CAGR of 21.18% from 2024 to 2030. Major factors contributing to this growth include the growing adoption of regenerative medicine, the rising number of clinical trials on cell therapi... Read More »
April 2024The U.S. antisense and RNAi therapeutics market size was estimated at USD 2.76 billion in 2023 and is expected to grow at a CAGR of 19.10% from 2024 to 2030. Multidisciplinary applications of antisense technology in various diseases, growing cancer prevalence, and favorable government in... Read More »
April 2024The Middle East stem cell market size was estimated at USD 694.0 million in 2023 and is projected to witness a CAGR of 7.56% from 2024 to 2030. The market’s growth can be attributed to the rising prevalence of chronic diseases such as cardiovascular diseases, and cancer. Growing aw... Read More »
March 2024The U.S. cell banking outsourcing market size was estimated at USD 5.16 billion in 2023 and is expected to grow at a CAGR of 14.79% from 2024 to 2030. The driving factors for this growth include the rising cryopreservation & cell bank preparation methodologies, and escalating demand ... Read More »
March 2024The U.S. downstream processing market size was estimated at USD 11.35 billion in 2023 and is expected to grow at a CAGR of 14.3% from 2024 to 2030. Major players are focused on streamlining the downstream process and reducing the overall cost of the procedure and the product. Downstream ... Read More »
March 2024The U.S. Cell and gene therapy manufacturing market was valued at USD 3.89 billion in 2023. It is anticipated to experience a CAGR of 27.1% from 2024 to 2030. Advanced therapies have significantly impacted the treatment of numerous rare and life-threatening diseases and revolutionized th... Read More »
March 2024The U.S. gene synthesis market size was estimated at USD 691.1 million in 2023 and is expected to grow at a CAGR of 16.0% from 2024 to 2030. The market growth is significantly influenced by the presence of several key market participants offering gene synthesis services and increasing in... Read More »
March 2024The U.S. life science tools market size was estimated at USD 56.61 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2030. This can be attributed to a rise in government funding for life science technologies, growth of cell & gene therapies, increase in demand f... Read More »
March 2024The U.S. stem cells market size was estimated at USD 5.46 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.46% from 2024 to 2030. Increase in acceptance of regenerative medicine and rise in number of regulatory approvals of stem cell therapies are expe... Read More »
March 2024The U.S. CRISPR and Cas genes market size was valued at USD 1.07 billion in 2023 and is anticipated to grow at a CAGR of 16.5% from 2024 to 2030. Therapeutic applications of CRISPR and Cas genes, rising significance for gene editing, and the introduction of anti-CRISPR proteins are boost... Read More »
March 2024The U.S. protein labeling market size was estimated at USD 932.2 million in 2023 and is expected to grow at a CAGR of 8.09% from 2024 to 2030. The key growth factors include the development of high-throughput proteomics platforms, advancements in mass spectrometry, and the integration of... Read More »
March 2024The U.S. aptamers market size was valued at USD 950.3 million in 2023 and is expected to grow at a CAGR of 24.3% from 2024 to 2030. Recent innovations in purification, generation, and drug delivery for eliminating target cells have driven the attention of many researchers toward aptamers... Read More »
March 2024The U.S. gene therapy market size was estimated at USD 3.11 billion in 2023 and is expected to grow at a CAGR of 19.21% from 2024 to 2030. The gene therapy market includes DNA-based therapies involving the delivery of a functional copy of a defective gene or the correction of a mutated g... Read More »
March 2024The global clinical microbiology market size was estimated at USD 4.57 billion in 2023 and is projected to reach USD 6.60 billion by 2030, growing at a CAGR of 5.35% from 2024 to 2030. The growth can be attributed to the increasing demand for laboratory services to detect ... Read More »
March 2024The global lipid nanoparticle raw materials market size was estimated at USD 224.5 million in 2023 and is projected to reach USD 329.2 million by 2030, growing at a CAGR of 5.66% from 2024 to 2030. The market growth is attributed to factors such as increasing demand for drugs that utiliz... Read More »
March 2024The global sequencing market size was estimated at USD 15,540.0 million in 2023 and is projected to reach USD 62,478.8 million by 2030, growing at a CAGR of 22.2% from 2024 to 2030. The market growth is attributed to factors such as growing demand for gene therapy, personalized medicine, drug discovery, increas... Read More »
February 2024The global retinal biologics market size was valued at USD 23.01 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.91% from 2024 to 2030. The launch of various drug products targeting retinal diseases and rising market competition is anticipated to driv... Read More »
February 2024The global liquid handling technology market size was estimated at USD 5.36 billion in 2023 and is projected to reach USD 9.63 billion by 2030, growing at a CAGR of 8.76% from 2024 to 2030. In recent years, the market has shown significant expansion potential due to t... Read More »
January 2024